News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Optimi Health Acquires Extensive Catalog of Psychedelic and Functional Mushroom Genetics
Optimi Health
Awakn Life Sciences Appoints UK Leader in Addictions Psychiatry, Dr. Arun Dhandayudham, as Chief Medical Officer
Awakn Life Sciences
Mydecine Announces First Quarter 2022 Financial Results and Highlights
Mydecine Innovations Group
MindMed Announces At-The-Market Offering
Mind Medicine (MindMed)
Albert Labs Granted Health Canada Licence
Albert Labs
atai Life Sciences Reports First Quarter 2022 Financial Results and Business Update
ATAI Life Sciences
PsyBio Therapeutics Develops Commercial Purification Process for Second Generation Psycho-Targeted Compound
PsyBio Therapeutics
MindMed Reports First Quarter 2022 Financial Results and Business Highlights
Mind Medicine (MindMed)
Weekly Headlines | May 13th
Cybin Inc.
Wesana Health
Tryp Therapeutics
Mind Medicine (MindMed)
Field Trip Health
Clearmind Announces Pre-IND Meeting Date with FDA
Clearmind Medicine
COMPASS Pathways to participate in upcoming Citi’s Biopharma Virtual Co-Panel Day and H.C. Wainwright Global Investment Conference
Compass Pathways
Enveric Biosciences to Host Fireside Chat with Dr. Bob Dagher, Chief Medical Officer, on May 17th at 10:00 a.m. ET
Enveric Biosciences
Mindset Pharma Progresses Plans for Clinical Trials of its Advanced Pre-Clinical Psychedelic, MSP-1014
Mindset Pharma
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.